{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:00:55Z","timestamp":1777870855716,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI150360"],"award-info":[{"award-number":["R01AI150360"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajog.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:28:39Z","timestamp":1741454919000},"page":"188.e1-188.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preference, adherence, and acceptability of 3 nonmedicated intravaginal rings of differing external diameters: a randomized, crossover trial"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-3634","authenticated-orcid":false,"given":"Barbara A.","family":"Friedland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Sales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Atrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena G.","family":"Plagianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Brady","family":"Burnett-Zieman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakti","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Roselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Rolston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Gottert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene V.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caio","family":"Sant'Anna Marinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Merkatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajog.2025.03.001_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.contraception.2012.08.037","article-title":"Current status of contraceptive vaginal rings","volume":"87","author":"Brache","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2025.03.001_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/IJWH.S34030","article-title":"Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies","volume":"5","author":"Thurman","year":"2013","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2025.03.001_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/17425247.2016.1134485","article-title":"An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy","volume":"13","author":"Friend","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ajog.2025.03.001_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2015.12.043","article-title":"Development of controlled release systems over the past 50years in the area of contraception","volume":"240","author":"Friend","year":"2016","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.ajog.2025.03.001_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1389450116666150505154720","article-title":"Current perspectives on novel drug delivery systems and approaches for management of cervical cancer: a comprehensive review","volume":"17","author":"Hani","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ajog.2025.03.001_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamaoncol.2016.3904","article-title":"Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial","volume":"3","author":"Melisko","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2025.03.001_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00404-017-4448-z","article-title":"\u201cPer vaginam\u201d topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review","volume":"296","author":"Buggio","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.03.001_bib9","series-title":"Williams Obstetrics","author":"Cunningham","year":"2018"},{"key":"10.1016\/j.ajog.2025.03.001_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/17425247.2020.1798927","article-title":"The ins and outs of drug-releasing vaginal rings: a literature review of expulsions and removals","volume":"17","author":"Boyd","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"10.1016\/j.ajog.2025.03.001_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.contraception.2014.05.015","article-title":"Acceptability of the Nestorone\u00ae\/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction","volume":"90","author":"Merkatz","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2025.03.001_bib12","series-title":"Drug Delivery and Development of Anti-HIV Microbicides","first-page":"569","article-title":"Socioeconomic and behavioral factors influencing choice, adherence, and success of microbicide formulations","author":"Tolley","year":"2014"},{"key":"10.1016\/j.ajog.2025.03.001_bib13","doi-asserted-by":"crossref","unstructured":"Gottert A, Friedland BA, Plagianos M, et al. Development and validation of a multidimensional Intravaginal Ring Acceptability Scale among US women and their male partners. Perspect Sex Reprod Health 2025;57:144-53. https:\/\/doi.org\/10.1111\/psrh.70009.","DOI":"10.1111\/psrh.70009"},{"key":"10.1016\/j.ajog.2025.03.001_bib14","first-page":"149","article-title":"Experimental designs balanced for the estimation of residual effects of treatments","volume":"2","author":"Williams","year":"1949","journal-title":"Aust J Chem"},{"issue":"1","key":"10.1016\/j.ajog.2025.03.001_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13625180701577122","article-title":"Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany","volume":"13","author":"Brucker","year":"2008","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"issue":"6","key":"10.1016\/j.ajog.2025.03.001_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/13625187.2010.524717","article-title":"Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use","volume":"15","author":"Merki-Feld","year":"2010","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"issue":"3","key":"10.1016\/j.ajog.2025.03.001_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13625180701440180","article-title":"Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages","volume":"12","author":"Merki-Feld","year":"2007","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"issue":"1","key":"10.1016\/j.ajog.2025.03.001_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13625180500389547","article-title":"The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands","volume":"11","author":"Roumen","year":"2006","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"issue":"2","key":"10.1016\/j.ajog.2025.03.001_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2004.08.010","article-title":"Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial","volume":"71","author":"Sivin","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ajog.2025.03.001_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0010-7824(91)90040-M","article-title":"The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort","volume":"43","author":"Elder","year":"1991","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ajog.2025.03.001_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-7824(90)90142-I","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World health organization. Task force on long-acting systemic agents for fertility regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2025.03.001_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10461-019-02514-8","article-title":"Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe","volume":"24","author":"Duby","year":"2020","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ajog.2025.03.001_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/QAI.0000000000002990","article-title":"Patterns of adherence to a dapivirine vaginal ring for HIV-1 prevention among South African women in a phase III randomized controlled trial","volume":"90","author":"Browne","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.ajog.2025.03.001_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.contraception.2017.12.011","article-title":"Factors associated with nonadherence to instructions for using the Nestorone\u00ae\/ethinyl estradiol contraceptive vaginal ring","volume":"97","author":"Stifani","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2025.03.001_bib26","doi-asserted-by":"crossref","first-page":"548.e1","DOI":"10.1016\/j.ajog.2024.01.020","article-title":"Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system","volume":"230","author":"Plagianos","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.001_bib27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"key":"10.1016\/j.ajog.2025.03.001_bib28","first-page":"40","article-title":"Faking it: social desirability response bias in self-report research","volume":"25","author":"van de Mortel","year":"2008","journal-title":"Aust J Adv Nurs"},{"key":"10.1016\/j.ajog.2025.03.001_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10508422.2022.2093201","article-title":"The importance and efficacy of controlling for social desirability response bias","volume":"33","author":"Bernardi","year":"2023","journal-title":"Ethics Behav"},{"key":"10.1016\/j.ajog.2025.03.001_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/fampra\/cmz042","article-title":"Recall bias and reduction measures: an example in primary health care service utilization","volume":"36","author":"Khare","year":"2019","journal-title":"Fam Pract"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:47:04Z","timestamp":1777567624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0002937825001449"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.03.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preference, adherence, and acceptability of 3 nonmedicated intravaginal rings of differing external diameters: a randomized, crossover trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}